●The dark side of C5a in sepsis. Ward, P. A. Nature Reviews Immunology February (2004)

●Patent protection for protein structure analysis. Shimbo, I. et al. Nature Biotechnology January (2004)

●Using human neural stem cells to model neurological disease. Jakel, R. J., Schneider, B. L. & Svendsen, C. N. Nature Reviews Genetics February (2004)

●Virus entry: molecular mechanisms and biomedical applications. Dimitrov, D. S. Nature Reviews Microbiology February (2004)

●The STATs of cancer: new molecular targets come of age. Yu, H. & Jove, R. Nature Reviews Cancer February (2004)

●Nuclear transport and cancer: from mechanism to intervention. Kau, T. R., Way, J. C. & Silver, P. A. Nature Reviews Cancer February (2004)

●Proactive accounting: a key factor in the success of biotechnology startups. Jester, C. C. Nature Biotechnology (Bioentrepreneur) January (2004)

●Elucidation of Lyme arthritis. Steere, A. C. & Glickstein, L. Nature Reviews Immunology February (2004)

●Bacterial biofilms: survival and propagation on surfaces from the environment to infectious diseases. Hall-Stoodley, L., Costerton, J. W. & Stoodley, P. Nature Reviews Microbiology February (2004)

●Population and evolutionary dynamics of phage therapy. Levin, B. R. & Bull, J. J. Nature Reviews Microbiology February (2004)

●Old dogma, new tricks – 21st century phage therapy. Thiel, K. Nature Biotechnology January (2004)

●The biological magic behind the bullets. Stockwell, B. R. Nature Biotechnology January (2004)

●Pathogenic Escherichia coli. Kaper, J. B., Nataro, J. P. & Mobley, H. L. T. Nature Reviews Microbiology February (2004)

●Monoclonal antibodies: story of a discovery that revolutionized science and medicine. Alkan, S. S. Nature Reviews Immunology February (2004)